Physician profile
Marc E Cordero
NPI 1710189840
$6,816.73
in general payments reported to CMS, 2019-2025
28 companies · $478 in 2025
The $478 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,223 · 2020: $246 · 2021: $620 · 2022: $1,000 · 2023: $954 · 2024: $296 · 2025: $478.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,729.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,728.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $1,127.63 | 2019-2024 | Ventralight St, Phasix Mesh |
| Smith+Nephew, INC. | $1,113.43 | 2019-2024 | Grafix Pl, Collagenase Santyl |
| Karl Storz Endoscopy-America | $1,045.03 | 2019 | |
| Arthrex, INC. | $661.50 | 2019 | |
| Stryker Corporation | $571.70 | 2019 | |
| Mid-Atlantic Surgical Systems, LLC | $529.29 | 2019 | |
| Tela Bio, INC. | $372.32 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Inari Medical, INC. | $219.67 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Innocoll Pharmaceuticals Limited | $171.12 | 2021 | |
| Solventum Corporation | $149.99 | 2025 | V.A.C.Ulta |
| Medtronic, INC. | $146.54 | 2023 | Interstim |
| Becton, Dickinson and Company | $132.86 | 2023-2025 | Phasix Mesh |
| Merck Sharp & Dohme LLC | $91.96 | 2022-2025 | Zerbaxa, Dificid, Recarbrio |
| Averitas Pharma INC. | $87.28 | 2024-2025 | Qutenza |
| Misonix INC | $76.48 | 2019 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $65.78 | 2019-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Integra Lifesciences Corporation | $36.46 | 2019-2023 | Integra, Surgimend, Omnigraft |
| Baxter Healthcare | $29.52 | 2025 | Perclot |
| Cumberland Pharmaceuticals, INC. | $26.59 | 2023 | Vibativ |
| Hydrofera LLC | $24.38 | 2025 | Hydrofera Blue |
| Intuitive Surgical, INC. | $23.04 | 2024 | |
| Bioventus LLC | $20.90 | 2022 | |
| Acera Surgical, INC. | $20.48 | 2023 | Restrata Wound Matrix |
| Urgo Medical North America, LLC | $18.10 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Hartmann USA, INC. | $14.49 | 2023 | Zetuvit Plus |
| Kci USA, INC. | $13.64 | 2022 | |
| Paratek Pharmaceuticals, INC. | $13.32 | 2020 | |
| Kerecis Limited | $13.23 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Cordero listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.